Table II.
Baseline Patient Characteristics
| Variable | Total (N=51) |
|---|---|
| Age in years (median, range) | 76.0 (60.0, 89.0) |
| Gender | |
| Male | 23 (45.1%) |
| Female | 28 (54.9%) |
| Race | |
| White | 44 (86.3%) |
| Black | 6 (11.8%) |
| Unknown | 1 (2.0%) |
| Ethnicity | |
| Hispanic or Latino | 4 (7.8%) |
| Not Hispanic | 43 (84.3%) |
| Not Reported/Unknown | 4 (7.8%) |
| Performance score | |
| 0 | 9 (17.6%) |
| 1 | 29 (56.9%) |
| 2 | 13 (25.5%) |
| Histology | |
| Squamous | 19 (37.3%) |
| Adenocarcinoma | 24 (47.1%) |
| Bronchoalveolar | 1 (2.0%) |
| Other non-small cell carcinoma | 4 (7.8%) |
| Other, specify* | 3 (5.9%) |
| Tumor stage: T1 | 51 (100.0%) |
| N stage: N0 | 51 (100.0%) |
| M stage: M0 | 51 (100.0%) |
| Stage: IA | 51 (100.0%) |
| Size of nodule in cm (median, range) | 2.0 (0.8–3.0) |
| Maximum Tumor Dimension in cm (median, range) | 2.1 (0.8–3.0) |
| Tumor SUV (median, range) | 6.0 (0.6, 15.1) |
| Tumor location | |
| Left lower lobe | 6 (11.8%) |
| Right lower lobe | 6 (11.8%) |
| Left upper lobe | 16 (31.4%) |
| Right upper lobe | 20 (39.2%) |
| Right middle lobe | 2 (3.9%) |
| Right lower lobe/Right upper lobe | 1 (2.0%) |
| Baseline FEV1 % predicted (Mean, Median, Range) | 48.8, 48.0, (13.0, 102.0) |
| Baseline DLCO % predicted (Mean, Median, Range) | 43.7, 42.0, (7.0, 99.0) |
| Baseline FVC (ml) (Mean, Median, Range) | 2046.6, 2070.0, (1090.0, 3720.0) |
*
: Poorly differentiate non-small cell carcinoma; Non-small cell carcinoma subtype information not available; Large cell carcinoma with squamous cell feature;